Cathay Biotech Inc.

Name: Cathay Biotech Inc. Financial Statements
Creator: AlphaPilot

688065.SS · SHH

	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	CN¥2,958	CN¥2,114	CN¥2,441	CN¥2,363
% Growth	39.9%	-13.4%	3.3%	–
Cost of Goods Sold	CN¥2,121	CN¥1,535	CN¥1,612	CN¥1,526
Gross Profit	CN¥836	CN¥579	CN¥829	CN¥837
% Margin	28.3%	27.4%	34%	35.4%
R&D Expenses	CN¥233	CN¥189	CN¥188	CN¥134
G&A Expenses	CN¥167	CN¥183	CN¥187	CN¥133
SG&A Expenses	CN¥222	CN¥222	CN¥232	CN¥175
Sales & Mktg Exp.	CN¥55	CN¥38	CN¥45	CN¥42
Other Operating Expenses	-CN¥170	-CN¥286	-CN¥299	-CN¥195
Operating Expenses	CN¥285	CN¥125	CN¥121	CN¥114
Operating Income	CN¥552	CN¥454	CN¥708	CN¥723
% Margin	18.6%	21.5%	29%	30.6%
Other Income/Exp. Net	-CN¥4	-CN¥5	-CN¥12	CN¥1
Pre-Tax Income	CN¥548	CN¥449	CN¥696	CN¥724
Tax Expense	CN¥73	CN¥40	CN¥83	CN¥91
Net Income	CN¥489	CN¥367	CN¥553	CN¥595
% Margin	16.5%	17.3%	22.7%	25.2%
EPS	0.84	0.63	0.95	1.43
% Growth	33.3%	-33.7%	-33.6%	–
EPS Diluted	0.84	0.63	0.95	1.43
Weighted Avg Shares Out	582	582	582	416
Weighted Avg Shares Out Dil	582	582	582	416
Supplemental Information	–	–	–	–
Interest Income	CN¥161	CN¥220	CN¥237	CN¥213
Interest Expense	CN¥33	CN¥38	CN¥25	CN¥16
Depreciation & Amortization	CN¥316	CN¥286	CN¥265	CN¥169
EBITDA	CN¥680	CN¥451	CN¥672	CN¥668
% Margin	23%	21.3%	27.5%	28.3%